Controversy regarding ACE inhibitors / ARBs in COVID-19

被引：11
|
作者：
Soria Arcos, Federico [1 ]
Romero Puche, Antonio [2 ]
Vicente Vera, Tomas [2 ]
机构：
[1] Hosp Santa Lucia, Serv Cardiol, Murcia, Spain
[2] Hosp Reina Sofia, Serv Cardiol, Murcia, Spain
来源：
REVISTA ESPANOLA DE CARDIOLOGIA | 2020年 / 73卷 / 06期
关键词：
D O I：
10.1016/j.recesp.2020.03.014
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：516 / 516
页数：1
相关论文
共 50 条
  • [1] The effect of ACE inhibitors and ARBs on outcomes in hospitalized patients with COVID-19
    Narges Najafi
    Alireza Davoudi
    Hamideh Izadyar
    Abbas Alishahi
    Armaghan Mokhtariani
    Bahareh Soleimanpourian
    Mina Tabarrayi
    Mahmood Moosazadeh
    Zahra Daftarian
    Fatemeh Ahangarkani
    Irish Journal of Medical Science (1971 -), 2023, 192 (3): : 1517 - 1523
  • [2] The effect of ACE inhibitors and ARBs on outcomes in hospitalized patients with COVID-19
    Najafi, Narges
    Davoudi, Alireza
    Izadyar, Hamideh
    Alishahi, Abbas
    Mokhtariani, Armaghan
    Soleimanpourian, Bahareh
    Tabarrayi, Mina
    Moosazadeh, Mahmood
    Daftarian, Zahra
    Ahangarkani, Fatemeh
    IRISH JOURNAL OF MEDICAL SCIENCE, 2023, 192 (03) : 1517 - 1523
  • [3] ARBS AND ACE INHIBITORS ARE ASSOCIATED WITH IMPROVED OUTCOMES IN MALES HOSPITALIZED WITH COVID-19
    Rocheleau, Genevieve
    Lee, Terry
    Mohammed, Yassene
    Goodlet, David
    Burns, Kevin
    Cheng, Matthew
    Tran, Karen
    Russell, James
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 11 - 11
  • [4] Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs
    Byttebier, Geert
    Belmans, Luc
    Alexander, Myriam
    Saxberg, Bo E. H.
    De Spiegeleer, Bart
    De Spiegeleer, Anton
    Devreker, Nick
    Van Praet, Jens T.
    Vanhove, Karolien
    Reybrouck, Reinhilde
    Wynendaele, Evelien
    Fedson, David S.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (09) : 2841 - 2850
  • [5] Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients
    Rossi, Gian Paolo
    Sanga, Viola
    Barton, Matthias
    ELIFE, 2020, 9
  • [6] The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19
    Braude, Philip
    Carter, Ben
    Short, Roxanna
    Vilches-Moraga, Arturo
    Verduri, Alessia
    Pearce, Lyndsay
    Price, Angeline
    Quinn, Terence J.
    Stechman, Michael
    Collins, Jemima
    Bruce, Eilidh
    Einarsson, Alice
    Rickard, Frances
    Mitchell, Emma
    Holloway, Mark
    Hesford, James
    Barlow-Pay, Fenella
    Clini, Enrico
    Myint, Phyo Kyaw
    Moug, Susan
    McCarthy, Kathryn
    Hewitt, Jonathan
    IJC HEART & VASCULATURE, 2020, 31
  • [7] Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis
    Flacco, Maria Elena
    Martellucci, Cecilia Acuti
    Bravi, Francesca
    Parruti, Giustino
    Cappadona, Rosaria
    Mascitelli, Alfonso
    Manfredini, Roberto
    Mantovani, Lorenzo G.
    Manzoli, Lamberto
    HEART, 2020, 106 (19) : 1519 - +
  • [8] Keep taking your ACE inhibitors and ARBs during the COVID 19 pandemic
    Speth, Robert C.
    JOURNAL OF TRAVEL MEDICINE, 2020, 27 (03)
  • [9] ACEI inhibitors and ARBs do not increase severity of COVID-19
    Reactions Weekly, 2020, 1802 (1) : 5 - 5
  • [10] ACE inhibitors and ARBs in HFpEF
    Bryony M. Mearns
    Nature Reviews Cardiology, 2013, 10 (2) : 60 - 60
12345